Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2023 Jul 11;11(7):e006699corr1. doi: 10.1136/jitc-2023-006699corr1

Correction: Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy

PMCID: PMC10347463  PMID: 37433719

Lee L, Lim WC, Galas-Filipowicz D, et al. Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy. J ImmunoTher Cancer 2023; 11: e006699. doi: 10.1136/jitc-2023-006699

This article has been corrected since it was first published. Author name Kwee Yong has been corrected.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES